Resuscitation and Prevention of Ischemia-Induced Dysfunction (RAPIID) - TA3
DARPA-PA-26-09 · DEPT OF DEFENSE
A RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) solicitation, with responses due 2026-07-29. AwardCast estimates what this specific solicitation will close for, before you bid.
DARPA-PA-26-09
solicitation
541714
NAICS
AC12
PSC
Not set aside
set-aside
2026-07-29
responses due
What's being bought
Please note that this announcement specifically solicits proposals only for Task Area 3 (TA-3) of the RAPIID program. Primary challenges with translating technological advancements from the laboratory to real-world usage include a lack of investment to ensure manufacturing scalability, and usability
Comparable recent awards in RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
| Winner | Award value | Offers | Date |
|---|---|---|---|
| HJ SCIENCE & TECHNOLOGY INC | $167K | 7 | 2024-09-30 |
| NOU SYSTEMS INC | $167K | 7 | 2024-09-30 |
| WAKE FOREST UNIVERSITY HEALTH SCIENCES | $4.3M | 1 | 2024-09-30 |
| IXI TECHNOLOGY INC | $167K | 7 | 2024-09-30 |
| APPLIED RESEARCH ASSOCIATES, INC. | $2.5M | 1 | 2024-09-30 |
Explore the market
Comparable awards ran from $167K to $4.3M. Get AwardCast's forecast for THIS solicitation's closing price.
AwardCast forecasts what U.S. federal contracts close for, before you bid. Built on USASpending and SAM.gov. Not affiliated with the U.S. government. Technology by Chosing DEPT.